首页> 外国专利> Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy

Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy

机译:抗生物素蛋白二聚体可有效提高预靶向放射免疫疗法中放射性生物素的浓度

摘要

Dimers of avidin and streptavidins (diavidins) are described wherein the linker is suberate, which in turn, is bound to different functional groups (—NH2 o-COOH) of avidin. As compared to avidin, the diavidins have shown the ability to increase the amount of labelled biotin on the target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H. The use of such diavidins is also described in cancer diagnosis and anticancer therapy based on the three-step pretargeted radioimmunotherapy procedure.
机译:描述了抗生物素蛋白和抗生物素蛋白链菌素(二抗生物素蛋白)的二聚体,其中所述连接物为辛二酸酯,其进而与抗生物素蛋白的不同官能团(-NH 2 o-COOH)结合。与抗生物素蛋白相比,在使用支持的人腱糖蛋白,生物素化的抗腱糖蛋白单克隆抗体(Mab-B),抗生物素蛋白/进行体外预​​靶向测试时,抗生物素蛋白已显示出增加靶标上标记生物素数量的能力。亲和素和生物素3H。在基于三步预靶向放射免疫疗法程序的癌症诊断和抗癌治疗中,也描述了这种抗生物素蛋白的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号